*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>This combination is a fixed-dose pharmaceutical agent integrating <strong>Promethazine Hydrochloride</strong> (an antihistamine) and <strong>Dextromethorphan Hydrobromide</strong> (a cough suppressant). Synthesized via salt formation processes, it targets symptomatic relief for upper respiratory infections. The specific molecular composition varies by individual API but generally follows C17H20ClNO·HBr and C18H25NO3·HBr stoichiometries respectively.</p>
<h3>Application</h3>
<ul>
<li><strong>Cough & Cold Formulations:</strong> Used in oral syrups to manage dry coughs and allergic rhinitis symptoms.</li>
<li><strong>Respiratory Therapy:</strong> Provides dual-action relief for non-productive coughs associated with bronchitis or common colds.</li>
<li><strong>Otic Preparations:</strong> Occasionally utilized in compounded ear drops for pain and itching relief.</li>
</ul>
<h3>Precautions</h3>
<ul>
<li><strong>Contraindications:</strong> Strictly prohibited for children under two years due to respiratory depression risks.</li>
<li><strong>Storage:</strong> Store below 25°C in tightly sealed containers away from light and moisture.</li>
<li><strong>Safety:</strong> Requires handling protocols for CNS depressants; avoid operation of heavy machinery.</li>
</ul>